IL6 and myeloid sarcoma: In MS, neuroinflammation activates the MAPK signaling pathway within the nuclei of macrophages and dendritic cells, leading to the overproduction of pro-inflammatory cytokines, including TNF-α, IFN-γ, IL-1β, IL-12, IL-6, and IL-23 [160].